Subscribe To
Alnylam pharmaceuticals, inc. (alny) q2 2023 earnings call transcript
Alnylam pharmaceuticals, Inc. (NASDAQ:ALNY ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET...
August 3, 2023, 1:40 pm
Regeneron pharmaceuticals inc: a biotech powerhouse with high outperformance potential
Regeneron pharmaceuticals Inc ( REGN , Financial), a leading player in the biotechnology industry, is c...
August 3, 2023, 12:58 pm
Biocryst pharmaceuticals, inc. (bcrx) q2 2023 earnings call transcript
BioCryst pharmaceuticals, Inc. (NASDAQ:BCRX ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM E...
August 3, 2023, 12:55 pm
Teva agrees to pay $126 mln to us hospitals over opioids
Teva pharmaceutical Industries Ltd has agreed to pay up to $126 million to U.S. hospitals over 18 years...
August 3, 2023, 12:47 pm
Agios pharmaceuticals, inc. (agio) q2 2023 earnings call transcript
Agios pharmaceuticals, Inc. (NASDAQ:AGIO ) Q2 2023 Results Conference Call August 3, 2023 8:00 AM ET Co...
August 3, 2023, 11:55 am
Drug sales surge drives regeneron pharmaceuticals to q2 beat
Regeneron pharmaceuticals Inc (NASDAQ:REGN) reported second-quarter revenue of $10.24 per share on ...
August 3, 2023, 10:40 am
Shareholder investigation: halper sadeh llc investigates reta, eqrx, dffn
NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...
August 3, 2023, 10:23 am
Aurinia pharmaceuticals (auph) reports q2 loss, tops revenue estimates
Aurinia pharmaceuticals (AUPH) came out with a quarterly loss of $0.08 per share versus the Zacks Conse...
August 3, 2023, 9:00 am
Moleculin to report second quarter financial results on august 11, 2023 and host conference call and webcast
HOUSTON , Aug. 3, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage ...
August 3, 2023, 8:45 am
Regeneron's stock rallies after profit, revenue rise above expectations, amid a jump in collaboration revenue
Shares of Regeneron pharmaceuticals Inc. REGN, -0.94% climbed 2.6% toward a 5-week high in premarket tr...
August 3, 2023, 8:11 am
Nkarta to participate at upcoming investor conference
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutica...
August 3, 2023, 8:02 am
Altimmune to report second quarter 2023 financial results and provide business update on august 10, 2023
GAITHERSBURG, Md., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharma...
August 3, 2023, 7:30 am
Plus therapeutics to present at the canaccord genuity 43rd annual growth conference
AUSTIN, Texas, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage ...
August 3, 2023, 7:00 am
Regeneron pharma beats profit estimates on dupixent demand
Regeneron pharmaceuticals Inc beat Wall Street estimates for quarterly profit on Thursday, driven by st...
August 3, 2023, 6:37 am
Here's why investors should buy these 2 medical stocks after earnings
Following their favorable Q2 reports now looks like a good time to buy Encompass Health (EHC) and Vertex pharm...
August 3, 2023, 2:59 am
Rocket pharmaceuticals: thriving gene therapy with multiple catalysts
Rocket pharmaceuticals is developing gene therapies for rare diseases, with positive results and safety...
August 3, 2023, 12:42 am
Quoin pharmaceuticals provides corporate update and announces second quarter 2023 financial results
Company reports positive clinical data for first subject to complete testing in ongoing open-label Netherton Syndrome study Subject’s skin was asses...
August 2, 2023, 8:45 pm
Ventyx biosciences to participate in the canaccord genuity 43rd annual growth conference
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage bio...
August 2, 2023, 8:06 pm
Acadia pharmaceuticals (acad) q2 earnings and revenues beat estimates
Acadia pharmaceuticals (ACAD) came out with quarterly earnings of $0.01 per share, beating the Zacks Co...
August 2, 2023, 6:43 pm
Vertex pharmaceuticals (vrtx): a fairly valued stock with strong growth prospects
Vertex pharmaceuticals Inc ( VRTX , Financial) saw a daily gain of 3.07%, with an Earnings Per Share (E...
August 2, 2023, 6:33 pm